A bracelet-like device that measures levels of troponin-I in the blood could provide a more efficient way of detecting a heart attack, according to US researchers.
Merck & Co has said building its cardiovascular medicines business is central to its strategy to manage the loss of patent protection of cancer juggernaut Keytruda in
Digital alerts tied to electronic health records (EHR) make it more likely that doctors prescribed medicines for heart failure in accordance with guidelines, according to
New data for Esperion’s cholesterol lowering daily pill Nexletol, used when statins are not working in people at risk of a heart attack, could inject some momentum into th
A major study in the UK will look at how effective a Huawei wearable device and artificial intelligence software from Brainomix are in the detection of atrial fibrillation
Novartis looks odds on to extend the indications of its CDK4/6 inhibitor Kisqali into early-stage breast cancer, on the back of data from the phase 3 NATALEE trial reporte
